Multiple Sclerosis, Primary Progressive: Clinical Trials

3 trials for Multiple Sclerosis, Primary Progressive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Multiple Sclerosis, Primary Progressive: new trials by email Literature Review of Multiple Sclerosis, Primary Progressive trials Research Report on Multiple Sclerosis, Primary Progressive

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF
PIPE-791 - Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis
Phase 1CompletedContineum Therapeutics162024-12-092025-08-06
Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
Insulin, Placebo (Sterile diluent) - Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive
Phase 1 / Phase 2CompletedJohns Hopkins University1052017-12-012023-03-10
Open-label Study of Liothyronine in MS
liothyronine - Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive
Phase 1CompletedJohns Hopkins University202015-07-012018-02-12

Narrower conditions

Multiple Sclerosis, Chronic Progressive (3)  ·  Multiple Sclerosis, Relapsing-Remitting (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Idiopathic Pulmonary Fibrosis (1)  ·  Immune System Diseases (1)  ·  Multiple Sclerosis (1)  ·  Nervous System Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  Pathologic Processes (1)  ·  Sclerosis (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Autoimmune Diseases (2)  ·  Autoimmune Diseases of the Nervous System (2)  ·  Demyelinating Autoimmune Diseases, CNS (2)  ·  Demyelinating Diseases (2)  ·  Immune System Diseases (2)  ·  Multiple Sclerosis (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Inflammation (1)  ·  Leukoencephalopathies (1)

Interventions

Insulin (1)  ·  Triiodothyronine (1)

Sponsors

Johns Hopkins University (2)  ·  Contineum Therapeutics (1)

Countries

United States (2)  ·  United Kingdom (1)

Top investigators

Scott Newsome, DO (2)  ·  Ellen Mowry, MD, MCR (1)  ·  Stephen Huhn, MD (1)